Search
US Weight-Loss Biotech Firm Kailera Secures $600 Million in Financing, with Bain Capital as Lead Investor
2025-10-15 /
Read about 0 minute
Author：小编
On October 14, 2025 (local time), Kailera Therapeutics, a biotech company based in the US that focuses on weight-loss solutions, proudly announced the successful closure of a Series B financing round, raising a substantial $600 million. The primary objective of this funding is to propel the development of innovative, next-generation drugs aimed at treating obesity. In this significant financing endeavor, Bain Capital emerged as the lead investor, while other prominent institutions, including the Canada Pension Plan Investment Board and the Qatar Investment Authority, also joined in to contribute.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
